Skip to content

Clinical trials

Phase 3 Stomach Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stomach Neoplasms Phase: Phase 3 Country / region: China Clear all

113 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20043
20052
20062
20071
20083
20093
20114
20124
20137
20144
20156
20165
20178
201811
20198
20209
20216
20224
20234
20245
20256
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status44
Completed30
Recruiting22
Active, not recruiting7
Terminated4
Not yet recruiting4
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sun Yat-sen University9
Fudan University8
Hoffmann-La Roche6
Merck Sharp & Dohme LLC6
Fujian Medical University4
AstraZeneca3
Chinese PLA General Hospital3
Chinese University of Hong Kong3
Huazhong University of Science and Technology3
Jiangsu HengRui Medicine Co., Ltd.3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stomach Neoplasms113
Adenocarcinoma7
Neoplasms4
Esophageal Neoplasms3
Stomach Diseases2
Colorectal Neoplasms1
Digestive System Neoplasms1
Gastroesophageal Reflux1
Lymphatic Metastasis1
Malnutrition1

Trials

Showing 1 to 25 of 113. Each trial links to its page on Pharma Observatory.

13 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.